0
Skip to Content
Translation-X
Home
News
Our Science
Team
Contact
Translation-X
Home
News
Our Science
Team
Contact
Home
News
Our Science
Team
Contact
Translation-X Advances to Final Round of 2025 >>venture>> Competition
Ozgur Genc 4/29/25 Ozgur Genc 4/29/25

Translation-X Advances to Final Round of 2025 >>venture>> Competition

Read More
Translation-X Secures full Venture Kick Support with a total of CHF 150,000 Funding
Ozgur Genc 4/29/25 Ozgur Genc 4/29/25

Translation-X Secures full Venture Kick Support with a total of CHF 150,000 Funding

Read More
Translation-X Moves Ahead with Venture Kick Stage 2 Success
Ozgur Genc 4/29/25 Ozgur Genc 4/29/25

Translation-X Moves Ahead with Venture Kick Stage 2 Success

Read More
Translation-X Presented at the 2nd Swiss RNA Therapeutics Summit
Ozgur Genc 4/29/25 Ozgur Genc 4/29/25

Translation-X Presented at the 2nd Swiss RNA Therapeutics Summit

Read More
Translation-X Featured at Slush Helsinki with Swissnex and HiLIFE
Ozgur Genc 4/29/25 Ozgur Genc 4/29/25

Translation-X Featured at Slush Helsinki with Swissnex and HiLIFE

Read More
Translation-X Wins Venture Kick's First Stage Support
Ozgur Genc 4/29/25 Ozgur Genc 4/29/25

Translation-X Wins Venture Kick's First Stage Support

Read More
Translation-X Awarded the Propelling Grant by Universität Basel
Ozgur Genc 4/29/25 Ozgur Genc 4/29/25

Translation-X Awarded the Propelling Grant by Universität Basel

Read More
Innosuisse Funds Translation-X's Autism Therapeutics Research
Ozgur Genc 4/29/25 Ozgur Genc 4/29/25

Innosuisse Funds Translation-X's Autism Therapeutics Research

Read More